Abstract
Anaplastic thyroid cancer (ATC) is among the most aggressive and unresectable tumors, presenting a bad prognosis. A better comprehension of the functional and molecular mechanisms behind the aggressiveness of this cancer, as well as new biomarkers for aggressiveness, prognosis, and response to therapy are required. However, owing to their irresectability, ATC tissue is not always accessible. Here we describe the establishment and characterization of a new patient-derived cell line, obtained from an unresectable ATC through fine-needle aspiration cytology (FNAC). The morphology, expression of epithelial and thyroid markers, cytogenetic, mutational and gene expression profiles, doubling time, and drug-resistance profile of the new cell line, designated C3948, were investigated using several methodologies: immunostaining, karyotype analysis, comparative genomic hybridization (CGH), fluorescent in situ hybridization (FISH), next-generation sequencing (NGS), Sanger sequencing, gene expression microarrays, cell counting, and IC50 determination. Results indicate that C3948 cell line has a histological phenotype representative of original ATC cells and a completely aberrant karyotype with many chromosomal losses and gains; harbors muta...Continue Reading
References
Aug 1, 1994·Genes, Chromosomes & Cancer·O P KallioniemiD Pinkel
Jan 1, 1993·The Journal of Clinical Investigation·J A FaginH P Koeffler
Oct 1, 1996·The Journal of Clinical Endocrinology and Metabolism·H AsakawaM Monden
Jan 31, 2003·Genes, Chromosomes & Cancer·Lucia RoqueJorge Soares
Mar 2, 2005·Cancer·Electron KebebewAlex McMillan
Aug 20, 2005·Human Mutation·Virpi Launonen
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicholas HearleRichard S Houlston
Apr 5, 2007·British Journal of Cancer·R F RodriguesV Leite
Aug 7, 2007·Nature·Hongbin JiKwok-Kin Wong
Jun 28, 2008·European Journal of Endocrinology·Alessandro AntonelliEle Ferrannini
Jul 12, 2008·Cancer Science·Frank StennerChristoph Renner
Nov 7, 2008·Endocrine-related Cancer·Robert C SmallridgeJohn A Copland
Mar 20, 2010·Nature Reviews. Cancer·Sreenath V SharmaJeff Settleman
Sep 3, 2010·The Journal of Clinical Endocrinology and Metabolism·Laura A MarlowJohn A Copland
Nov 8, 2012·Thyroid : Official Journal of the American Thyroid Association·Robert C SmallridgeUNKNOWN American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce
Jan 5, 2013·Biochimica Et Biophysica Acta·S E KorsseW van Veelen
Feb 23, 2013·Nature Reviews. Cancer·Mingzhao Xing
Apr 19, 2013·Nature·Hao-Ming ChangRichard I Gregory
Dec 21, 2013·World Journal of Surgery·Naoyoshi OnodaKosei Hirakawa
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Jaime Miguel PitaBranca Maria Cavaco
Sep 13, 2014·International Journal of Endocrinology·Moira RagazziSimonetta Piana
Nov 5, 2014·The Journal of Clinical Endocrinology and Metabolism·Manoj GargH Phillip Koeffler
Nov 25, 2014·Cell·UNKNOWN Cancer Genome Atlas Research Network
Jan 13, 2015·Human Molecular Genetics·John W KunstmanTobias Carling
Feb 16, 2016·The Journal of Clinical Investigation·Iñigo LandaJames A Fagin
Jun 2, 2016·American Journal of Clinical Pathology·Gang ZhengMing-Tseh Lin
Jul 5, 2017·Endocrine-related Cancer·Eleanor L WoodwardKajsa Paulsson
Apr 5, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nikita PozdeyevDaniel W Bowles
Apr 17, 2018·Japanese Journal of Clinical Oncology·Yoichi NaitoMotohiro Kojima
Jul 4, 2018·Journal of Endocrinological Investigation·J Simões-PereiraB M Cavaco
Sep 8, 2018·Journal of Endocrinological Investigation·S Lopes-VenturaB M Cavaco
Feb 10, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Iñigo LandaRebecca E Schweppe